Suppr超能文献

基于体素的三维剂量学预测叶状放射性栓塞后对侧肥大和足够的未来肝残留量。

3D voxel-based dosimetry to predict contralateral hypertrophy and an adequate future liver remnant after lobar radioembolization.

机构信息

Department of Nuclear Medicine, Clínica Universidad de Navarra, Pamplona, Spain.

Department of Medical Physics, Clínica Universidad de Navarra, Pamplona, Spain.

出版信息

Eur J Nucl Med Mol Imaging. 2021 Sep;48(10):3048-3057. doi: 10.1007/s00259-021-05272-9. Epub 2021 Mar 5.

Abstract

INTRODUCTION

Volume changes induced by selective internal radiation therapy (SIRT) may increase the possibility of tumor resection in patients with insufficient future liver remnant (FLR). The aim was to identify dosimetric and clinical parameters associated with contralateral hepatic hypertrophy after lobar/extended lobar SIRT with Y-resin microspheres.

MATERIALS AND METHODS

Patients underwent Y PET/CT after lobar or extended lobar (right + segment IV) SIRT. Y voxel dosimetry was retrospectively performed (PLANET Dose; DOSIsoft SA). Mean absorbed doses to tumoral/non-tumoral-treated volumes (NTL) and dose-volume histograms were extracted. Clinical variables were collected. Patients were stratified by FLR at baseline (T0-FLR): < 30% (would require hypertrophy) and ≥ 30%. Changes in volume of the treated, non-treated liver, and FLR were calculated at < 2 (T1), 2-5 (T2), and 6-12 months (T3) post-SIRT. Univariable and multivariable regression analyses were performed to identify predictors of atrophy, hypertrophy, and increase in FLR. The best cut-off value to predict an increase of FLR to ≥ 40% was defined using ROC analysis.

RESULTS

Fifty-six patients were studied; most had primary liver tumors (71.4%), 40.4% had cirrhosis, and 39.3% had been previously treated with chemotherapy. FLR in patients with T0-FLR < 30% increased progressively (T0: 25.2%; T1: 32.7%; T2: 38.1%; T3: 44.7%). No dosimetric parameter predicted atrophy. Both NTL-Dmean and NTL-V30 (fraction of NTL exposed to ≥ 30 Gy) were predictive of increase in FLR in patients with T0 FLR < 30%, the latter also in the total cohort of patients. Hypertrophy was not significantly associated with tumor dose or tumor size. When ≥ 49% of NTL received ≥ 30 Gy, FLR increased to ≥ 40% (accuracy: 76.4% in all patients and 80.95% in T0-FLR < 30% patients).

CONCLUSION

NTL-Dmean and NTL exposed to ≥ 30 Gy (NTL-V30) were most significantly associated with increase in FLR (particularly among patients with T0-FLR < 30%). When half of NTL received ≥ 30 Gy, FLR increased to ≥ 40%, with higher accuracy among patients with T0-FLR < 30%.

摘要

简介

选择性内部放射治疗(SIRT)引起的体积变化可能会增加未来肝残留量(FLR)不足的患者进行肿瘤切除的可能性。目的是确定与 Y 树脂微球进行叶/扩展叶 SIRT 后对侧肝肥大相关的剂量学和临床参数。

材料和方法

患者在叶或扩展叶(右+段 IV)SIRT 后进行 Y PET/CT。回顾性进行 Y 体素剂量测定(PLANET Dose;DOSIsoft SA)。提取肿瘤/非肿瘤治疗体积(NTL)和剂量体积直方图的平均吸收剂量。收集临床变量。根据基线时的 FLR(T0-FLR)将患者分层:<30%(需要肥大)和≥30%。在 SIRT 后<2(T1)、2-5(T2)和 6-12 个月(T3)计算治疗、未治疗的肝脏和 FLR 的体积变化。进行单变量和多变量回归分析,以确定萎缩、肥大和 FLR 增加的预测因素。使用 ROC 分析定义预测 FLR 增加至≥40%的最佳截断值。

结果

研究了 56 名患者;大多数患有原发性肝癌(71.4%),40.4%患有肝硬化,39.3%之前接受过化疗。T0-FLR<30%的患者的 FLR 逐渐增加(T0:25.2%;T1:32.7%;T2:38.1%;T3:44.7%)。没有剂量学参数预测萎缩。NTL-Dmean 和 NTL-V30(暴露于≥30Gy 的 NTL 分数)均可预测 T0-FLR<30%的患者中 FLR 的增加,后者也可预测所有患者的 FLR 增加。肥大与肿瘤剂量或肿瘤大小无显著相关性。当≥49%的 NTL 接受≥30Gy 时,FLR 增加至≥40%(准确性:所有患者为 76.4%,T0-FLR<30%患者为 80.95%)。

结论

NTL-Dmean 和暴露于≥30Gy 的 NTL(NTL-V30)与 FLR 的增加最显著相关(尤其是在 T0-FLR<30%的患者中)。当 NTL 的一半接受≥30Gy 时,FLR 增加至≥40%,T0-FLR<30%的患者准确性更高。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验